Compositions and methods for treating endocrine diseases and disorders
US12171727B1 · kind B1 · utility
0Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 19, 2024 |
| Grant date | Dec 24, 2024 |
| Priority date | — |
| Expiry date | Aug 19, 2044 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/20
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are compounds and ligands, and compositions formed therewith, that modulate insulin secretion and suppress appetite by activating ectopic olfactory receptors. Also disclosed herein are methods for using the compositions to treat endocrine diseases, such as type-2 diabetes, and disorders, such as abnormal insulin secretion.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.